EDF-Guidelines
EDF-Guidelines is made and published by swiss4ward Europe S.L. AppBrain is an independent app data site and isn't affiliated with swiss4ward Europe S.L. The app name, icon, screenshots and description belong to swiss4ward Europe S.L. and are shown as published on the App Store.
AppBrain's verdict
- Last updated
- August 1, 2026
Rankings
App Store top chartsApp Store Rankings for EDF-Guidelines
Competitors
Similar apps and more from swiss4ward Europe S.L.Alternatives to EDF-Guidelines
More from swiss4ward Europe S.L.
Releases
Updates seen on the App Store- Version
- 1.7.1
- Launched
- August 2017
No changelog data
User feedback
Ratings and reviews on the App StoreComments on EDF-Guidelines for iOS
We don't have enough comments to show example comments. Please check back later.
Technology
Found in the app by AppBrain- Price
- Free
- App size
- 2.30 MB
- Content rating
- High
Technologies used by EDF-Guidelines
About the app and developer
About EDF-Guidelines
EDF-Guidelines is a medical app developed by swiss4ward Europe S.L.
What is the rating of EDF-Guidelines?
EDF-Guidelines has no ratings yet.
Is EDF-Guidelines free?
EDF-Guidelines is free. The app size is 2.30 MB. The latest version available is 1.7.1. The last update was on August 1, 2026.
What are the requirements for EDF-Guidelines?
The app has a content rating of High Maturity. The app has been available on the App Store since August 2017.
Developer information for swiss4ward Europe S.L.
Address:
Store listing
By swiss4ward Europe S.L., from the App Store
Description by swiss4ward Europe S.L. Written by the developer, not by AppBrain. Click to read.
The recommendations for the different treatment options are rated according to their strength. The guideline offers advice on patient monitoring, contraindications and adverse events.
Recommendations are also made for groups of patients who require special consideration when receiving psoriasis treatment, such as those with a history of malingnacy, HIV infection or impaired liver or kidney function.
The guideline has originally been published in the Journal of the European Academy of Dermatology and Venereology (JEADV) by Nast A, et al. J Eur Acad Dermatol Venereol. 2015 Dec;29(12):2277-94. doi: 10.1111/jdv.13354